Cancer susceptibility and the functions of BRCA1 and BRCA2.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cell

• Publication date

  2002-01-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0092-8674(02)00615-3PMID 11832208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA Double-Strand Breaks

  2002cited by this paper
• Conserved domains in the chicken homologue of BRCA2

  2002cited by this paper
• DNA double-strand breaks: signaling, repair and the cancer connection

  2001cited by this paper
• Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

  2001cited by this paper
• Break-induced replication: A review and an example in budding yeast

  2001cited by this paper
• Tumour suppressors (Communication arising): Effect of DNA damage on a BRCA1 complex

  2001cited by this paper
• Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation

  2001cited by this paper
• Chromosomal stability and the DNA double-stranded break connection

  2001cited by this paper
• A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression.

  2001cited by this paper
• Gene-expression profiles in hereditary breast cancer.

  2001cited by this paper
• BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• The human decatenation checkpoint

  2001cited by this paper
• Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

  2001cited by this paper
• Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

  2001cited by this paper
• Direct DNA binding by Brca1

  2001cited by this paper
• Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining

  2001cited by this paper
• TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

  2001cited by this paper
• The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.

  2001cited by this paper
• BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

  2001cited by this paper
• Mutation in Brca2 stimulates error‐prone homology‐directed repair of DNA double‐strand breaks occurring between repeated sequences

  2001cited by this paper
• With the ends in sight: images from the BRCA1 tumor suppressor

  2001cited by this paper
• Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

  2001cited by this paper
• Breast cancer genetics: What we know and what we need

  2001cited by this paper
• BRCA2 is required for homology-directed repair of chromosomal breaks.

  2001cited by this paper
• Structure of a BRCA1–BARD1 heterodimeric RING–RING complex

  2001cited by this paper
• Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

  2001cited by this paper
• Cell division: Mitotic kinases as regulators of cell division and its checkpoints

  2001cited by this paper
• The importance of repairing stalled replication forks

  2000cited by this paper
• Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response

  2000cited by this paper
• hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

  2000cited by this paper
• Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation.

  2000cited by this paper
• The breast cancer susceptibility gene, BRCA2: at the crossroads between DNA replication and recombination?

  2000cited by this paper
• Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

  2000cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• CBP/p300 interact with and function as transcriptional coactivators of BRCA1.

  2000cited by this paper
• DNA double strand break repair in mammalian cells.

  2000cited by this paper
• BREAST CANCER GENETICS: Implications for Clinical Practice

  2000cited by this paper
• BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.

  2000cited by this paper
• Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.

  2000cited by this paper
• In search of the tumour-suppressor functions of BRCA1 and BRCA2

  2000cited by this paper
• BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.

  2000cited by this paper
• Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1.

  2000cited by this paper
• A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

  2000cited by this paper
• BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications.

  2000cited by this paper
• Gross chromosomal rearrangements in Saccharomyces cerevisiae replication and recombination defective mutants

  1999cited by this paper
• BRCA1 interacts with components of the histone deacetylase complex.

  1999cited by this paper
• BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.

  1999cited by this paper
• Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.

  1999cited by this paper
• Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50.

  1999cited by this paper
• Brca1 controls homology-directed DNA repair.

  1999cited by this paper
• DNA repair. Gatekeepers of recombination.

  1999cited by this paper
• Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

  1999cited by this paper
• Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

  1999cited by this paper
• BRCA1 inhibition of estrogen receptor signaling in transfected cells.

  1999cited by this paper
• Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

  1999cited by this paper
• DNA repair: Gatekeepers of recombination

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

  1999cited by this paper
• BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene

  1999cited by this paper
• How many more breast cancer predisposition genes are there?

  1999cited by this paper
• Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.

  1999cited by this paper
• Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1998cited by this paper
• Involvement of Brca2 in DNA repair.

  1998cited by this paper
• Chromosomal rearrangements occur in S. cerevisiae rfa1 mutator mutants due to mutagenic lesions processed by double-strand-break repair.

  1998cited by this paper
• BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A

  1998cited by this paper
• BRCA1 required for transcription-coupled repair of oxidative DNA damage.

  1998cited by this paper
• BRCA2 associates with acetyltransferase activity when bound to P/CAF

  1998cited by this paper
• RuvAB acts at arrested replication forks.

  1998cited by this paper
• Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

  1998cited by this paper
• BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.

  1998cited by this paper
• Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

  1997cited by this paper
• Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.

  1997cited by this paper
• Holliday junctions accumulate in replication mutants via a RecA homolog-independent mechanism.

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Gatekeepers and caretakers

  1997cited by this paper
• RAD51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2 *

  1997cited by this paper
• Cancer-susceptibility genes. Gatekeepers and caretakers.

  1997cited by this paper
• Brca2 is required for embryonic cellular proliferation in the mouse.

  1997cited by this paper
• DNA double‐strand breaks caused by replication arrest

  1997cited by this paper

• Frontiers in Cell-Cycle-Targeting Therapies: Addressing the Heterogeneity of the Cancer Cell Cycle

  2026cites this paper
• Impeding the NHEJ Pathway for Overcoming Radioresistance in the Context of Precision Radiotherapy of Cancer

  2026cites this paper
• Breast Cancer Disparities in African and African-Ancestry Populations: Genetics, Epigenetics, Structural Barriers and Technology-Enabled Solutions

  2026cites this paper
• Increased sensitivity of etoposide-treated breast cancer cells with an ATM inhibitor

  2026cites this paper
• Oncogenic competence: balancing mutations, cellular state, and microenvironment.

  2025cites this paper
• Gastrointestinal cancer: molecular pathogenesis and targeted therapy

  2025cites this paper
• Identification of potential therapeutic targeting in ovarian aging from genetic screening with clinical validation

  2025cites this paper
• CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysis

  2025cites this paper
• BRCA1 deficiency leads to aberrant epithelial differentiation in the thymus

  2025cites this paper
• Bioisosterism: an approach to develop new anti-cancer agents.

  2025cites this paper
• Human Cancers Derived from Either Genetic or Lifestyle Factors Are Initiated by Impaired Estrogen Signaling

  2025cites this paper
• Replication stress promotes cellular transformation in Drosophila epithelium

  2025cites this paper
• Molecular crowding and amyloidogenic self-assembly: Emergent perspectives from modern computations.

  2025cites this paper
• Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers

  2025cites this paper
• Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish Women

  2025cites this paper
• Stronger preference of human tumor suppressor protein BRCA1 for an open-planar Holliday junction: Insights from a combined spectroscopic and computational study.

  2025cites this paper
• Advances in cancer genomics and precision oncology

  2025cites this paper
• Exploring the Ligandability of 53BP1 through Fragment-Based Approaches.

  2025cites this paper
• Identification of antimicrobial peptides from the Ambystoma mexicanum displaying antibacterial and antitumor activity

  2025cites this paper
• Single-Nucleotide Polymorphisms of BRCA1 and BRCA2 and Risk of Papillary Thyroid Carcinoma

  2025cites this paper
• The Landscape of PARP Inhibitors in Solid Cancers

  2025cites this paper
• BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM

  2025cites this paper
• Synergistic Effects of Radiotherapy and PD‑1 Blockade in a Human‑Mimetic BRCAness Model of Triple-Negative Breast Cancer

  2025cites this paper
• Clinical Sequence Revealed the Prevalence and Biological Significance of Somatic Pathogenic Variants in Thoracic Cancer: Implications for Germline Status.

  2025cites this paper
• An Explainable Multimodal Artificial Intelligence Model Integrating Histopathological Microenvironment and EHR Phenotypes for Germline Genetic Testing in Breast Cancer

  2025cites this paper
• Enhancing clinical research with pharmacogenomics: a practical perspective.

  2025cites this paper
• The Hallmarks of Cancer as Eco-Evolutionary Processes.

  2025cites this paper
• TIPIN is essential for chromosome stability and cell viability in BRCA1-deficient cells.

  2025cites this paper
• The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression

  2025cites this paper
• Clinical Impact and Genomic Features of Human Epidermal Growth Factor Receptor 2–Low Tumors in BRCA1/2-Mutated Triple-Negative Breast Cancer

  2025cites this paper
• BRCA2 deficiency and replication stress drive APOBEC3-Mediated genomic instability

  2025cites this paper
• Structure-activity optimization of Deferasirox-derived aroyl hydrazones: Synthesis, DFT characterization, and mechanistic insights into selective anticancer activity against colon and breast cancer.

  2025cites this paper
• Androgen receptor‐mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer

  2025cites this paper
• Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models

  2024cites this paper
• BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality

  2024cites this paper
• Comprehensive review of milk fat globule membrane proteins across mammals and lactation periods in health and disease

  2024cites this paper
• Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy

  2024cites this paper
• A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivity

  2024cites this paper
• The role of rRNA in maintaining genome stability.

  2024cites this paper
• Toxicological effects of solvent-extracted organic matter associated with PM2.5 on human bronchial epithelial cell line NL-20.

  2024cites this paper
• PARP inhibitor resistant BRCA-mutated advanced breast cancer: current landscape and emerging treatments

  2024cites this paper
• Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma

  2024cites this paper
• DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care

  2024cites this paper
• Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors

  2024cites this paper
• Targeting the Cdc2‐like kinase 2 for overcoming platinum resistance in ovarian cancer

  2024cites this paper
• Concurrent Olaparib and Radiation Therapy for BRCA2-Mutated Breast Cancer

  2024cites this paper
• ER-positive and BRCA2-mutated breast cancer: a literature review

  2024cites this paper
• The deubiquitinating enzyme USP4 regulates BRCA1 stability and function

  2024cites this paper
• The discrepancy of somatic BRCA1/2 pathogenic variants from two different platforms in epithelial ovarian, fallopian tube, and peritoneal cancer

  2024cites this paper
• Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinoma.

  2024cites this paper
• Next-generation therapies for pancreatic cancer

  2024cites this paper
• The Future of Targeted Therapy for Leiomyosarcoma

  2024cites this paper
• Review on the Role of BRCA Mutations in Genomic Screening and Risk Stratification of Prostate Cancer

  2024cites this paper
• Combining evolution and protein language models for an interpretable cancer driver mutation prediction with D2Deep

  2024cites this paper
• Envisioning Clinical Management of Breast Cancer: a Comprehensive Review.

  2024cites this paper
• Platinum (IV) drugs with cannabidiol inducing mitochondrial dysfunction and synergistically enhancing anti-tumor effects.

  2024cites this paper
• HJURP is recruited to double-strand break sites and facilitates DNA repair by promoting chromatin reorganization

  2024cites this paper
• A MALDI-TOF mass spectrometry-based method for detection of copy number variations in BRCA1 and BRCA2 genes

  2024cites this paper
• Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study

  2024cites this paper
• Reversion of pathogenic BRCA1 L1780P mutation confers resistance to PARP and ATM inhibitor in breast cancer

  2024cites this paper
• Disparities in Hereditary Genetic Testing in Patients with Triple Negative Breast Cancer.

  2024cites this paper
• Systematic investigation of BRCA1-A, -B, and -C complexes and their functions in DNA damage response and DNA repair

  2024cites this paper
• PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition

  2024cites this paper
• Experimental methods to study the structure and dynamics of intrinsically disordered regions in proteins

  2024cites this paper
• Report of Cholangiocarcinoma With Transheterozygous BRCA1 and BRCA2 Co-mutation

  2024cites this paper
• Anti-Inflammatory and Anticancer Effects of Anthocyanins in In Vitro and In Vivo Studies

  2024cites this paper
• RAD18 directs DNA double-strand break repair by homologous recombination to post-replicative chromatin

  2024cites this paper
• BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors

  2024cites this paper
• The Role of Estrogen Receptors in Intracellular Estrogen Signaling Pathways, an overview.

  2024cites this paper
• Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling

  2023cites this paper
• Risk stratification based on DNA damage-repair-related signature reflects the microenvironmental feature, metabolic status and therapeutic response of breast cancer

  2023cites this paper
• Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight BRCA1 variants of uncertain significance by integrating available functional data with protein interaction assays

  2023cites this paper
• A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations

  2023cites this paper
• New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer

  2023cites this paper
• Genomic testing in high-grade serous ovarian cancer: current options and future development

  2023cites this paper
• BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil

  2023cites this paper
• Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer

  2023cites this paper
• Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2

  2023cites this paper
• RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer

  2023cites this paper
• Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments.

  2023cites this paper
• MATCHING BRCA AND PROSTATE CANCER IN A PUBLIC HEALTH SYSTEM: REPORT OF THE ITALIAN SOCIETY FOR URO-ONCOLOGY (SIUrO) CONSENSUS PROJECT.

  2023cites this paper
• Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine

  2023cites this paper
• Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review

  2023cites this paper
• Inter-BRCT linker is probably the most intolerant region of the BRCA1 BRCT domain

  2023cites this paper
• NMR‐identification of the interaction between BRCA1 and the intrinsically disordered monomer of the Myc‐associated factor X

  2023cites this paper
• Germline BRCA2 variant with low variant allele frequency detected in tumor‐only comprehensive genomic profiling

  2023cites this paper
• Developments in Genetics: Better Management of Ovarian Cancer Patients

  2023cites this paper
• Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility

  2023cites this paper
• The BRCA1/BARD1 complex recognizes pre-ribosomal RNA to facilitate homologous recombination

  2023cites this paper
• Potential agnostic role of BRCA alterations in patients with several solid tumors: one for all, all for one?

  2023cites this paper
• Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors

  2023cites this paper
• Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer

  2023cites this paper
• Impact of trifluoromethyl and sulfonyl groups on the biological activity of novel aryl-urea derivatives: synthesis, in-vitro, in-silico and SAR studies

  2023cites this paper
• Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells

  2023cites this paper
• Fanconi anemia pathway regulation by FANCI in prostate cancer

  2023cites this paper
• Efficacy of immune checkpoint inhibitor monotherapy or combined with other small molecule-targeted agents in ovarian cancer

  2023cites this paper
• Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting

  2023cites this paper
• Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants

  2023cites this paper
• Slow Dissociation from the PARP1–HPF1 Complex Drives Inhibitor Potency

  2023cites this paper
• BRCA1, BRCA2, TP53, PIK3CA, PTEN and AKT1 genes mutations in Burkina Faso breast cancer patients: prevalence, spectrum and novel variant

  2022cites this paper